Dr Mark Hudson-Peacock is an entrepreneur and the co-founder/Chairman and Medical Director of the eXroid group of companies and founder/Chairman and Medical Director of Mantara Health Ltd.
He launched the first commercially available Pharmacogenomics (PGx) test in the UK, which has full MHRA registration and CE and UKCA marks. With a passion for therapeutics, he aims to drive safer prescribing through evidence-based, affordable PGx products.
Understanding that around 90% of medications only work in 30–50% of patients, Dr Hudson-Peacock advocates personalised medicine using simple saliva tests to generate individual medication reports, improving patient outcomes and sustainability by reducing ineffective prescribing.